Genetic basis of autism: Is there a way forward?

Current Opinion in Psychiatry

Volumn 24, Issue 3, 2011, Pages 226-236

  Eapen, Valsamma ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b LIVERPOOL HOSPITAL   (Australia)

Author keywords

Autism; autism spectrum disorder; genetics

Indexed keywords

TRANSCRIPTOME;

ARTICLE; AUTISM; CHROMOSOME ABERRATION; COPY NUMBER VARIATION; ENVIRONMENTAL FACTOR; EPIGENETICS; GENE INTERACTION; GENETIC ANALYSIS; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HUMAN; INTELLECTUAL IMPAIRMENT; MUTATION; NERVE CELL NETWORK; NEUROSCIENCE; PATHOGENESIS; PHENOTYPE;

CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; EPIGENESIS, GENETIC; EPIGENOMICS; GENOTYPE; HUMANS; PHENOTYPE;

EID: 79955109852     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/YCO.0b013e328345927e     Document Type: Article

References (107)

1. Lichtenstein P, Carlstrom E, Rastam M, et al. The genetics of autism spectrum disorders and related neuropsychiatric disorders in childhood. Am J Psychiatry 2010; 167:1357-1363.
2. Bailey A, Le Couteur A, Gottesman I, et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 1995; 25:63-77.
3. O'Roak BJ, State MW. Autism genetics: strategies, challenges, and opportunities. Autism Res 2008; 1:4-17.
4. Pinto D, Pagnamenta AT, Klei L, et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 2010; 466:368-372.
5. Wang K, Zhang H, Ma D, et al. Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 2009; 459:528-533.
6. Abrahams BS, Geschwind DH. Connecting genes to brain in the autism spectrum disorders. Arch Neurol 2010; 67:395-399.
7. Betancur C. Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting. Brain Res 2011; 1380:42-77.
8. El-Fishawy P, State MW. The genetics of autism: key issues, recent findings, and clinical implications. Psychiatr Clin North Am 2010; 33:83-105.
9. Nishiyama T, Notohara M, Sumi S, et al. Major contribution of dominant inheritance to autism spectrum disorders (ASDs) in population-based families. J Hum Genet 2009; 54:721-726.
10. Reich DE, Lander ES. On the allelic spectrum of human disease. Trends Genet 2001; 17:502-510. (Pubitemid 32763048)
11. Iyengar SK, Elston RC. The genetic basis of complex traits: rare variants or 'common gene, common disease'? Methods Mol Biol 2007; 376:71-84. (Pubitemid 350189861)
12. Freitag CM, Staal W, Klauck SM, et al. Genetics of autistic disorders: review and clinical implications. Eur Child Adolesc Psychiatry 2010; 19:169-178.
13. Kumar RA, Sudi J, Babatz TD, et al. Ade novo 1p34.2 microdeletion identifies the synaptic vesicle gene RIMS3 as a novel candidate for autism. J Med Genet 2010; 47:81-90.
14. Arking DE, Cutler DJ, Brune CW, et al. A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. Am J Hum Genet 2008; 82:160-164. (Pubitemid 351726090)
15. Freitag CM, Agelopoulos K, Huy E, et al. Adenosine A(2A) receptor gene (ADORA2A) variants may increase autistic symptoms and anxiety in autism spectrum disorder. Eur Child Adolesc Psychiatry 2010; 19:67-74.
16. Alarcon M, Abrahams BS, Stone JL, et al. Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. Am J Hum Genet 2008; 82:150-159. (Pubitemid 351726082)
17. Merikangas AK, Corvin AP, Gallagher L. Copy-number variants in neurodevelopmental disorders: promises and challenges. Trends Genet 2009; 25:536-544.
18. McClellan J, King MC. Genetic heterogeneity in human disease. Cell 2010; 141:210-217.
19. Tost H, Kolachana B, Hakimi S, et al. A common allele in the oxytocin receptor gene (OXTR) impacts prosocial temperament and human hypothalamic-limbic structure and function. Proc Natl Acad Sci USA 2010; 107: 13936-13941.
20. Mitchell KJ. The genetics of neurodevelopmental disease. Curr Opin Neuro- biol 2011; 21:197-203.
21. Feuk L ASHG 2008 Annual Meeting: from enormous cohorts to individual genomes. Genome Med 2009; 1:9.
22. Weiss LA, Arking DE, Daly MJ, Chakravarti A. A genome-wide linkage and association scan reveals novel loci for autism. Nature 2009; 461:802-808.
23. Anney R, Klei L, Pinto D, et al. A genome-wide scan for common alleles affecting risk for autism. Hum Mol Genet 2010; 19:4072-4082.
24. Altshuler D, Daly MJ, Lander ES. Genetic mapping in human disease. Science 2008; 322:881-888.
25. Manolio TA. Genomewide association studies and assessment of the risk of disease. N Engl J Med 2010; 363:166-176.
26. Jamain S, Quach H, Betancur C, et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 2003; 34:27-29. (Pubitemid 36548785)
27. Gauthier J, Champagne N, Lafreniere RG, et al. De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia. Proc Natl Acad Sci USA 2010; 107:7863-7868.
28. Gauthier J, Spiegelman D, Piton A, et al. Novel de novo SHANK3 mutation in autistic patients. Am J Med Genet BNeuropsychiatr Genet 2009; 150B:421 - 424.
29. Berkel S, Marshall CR, Weiss B, et al. Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation. Nat Genet 2010; 42:489-491.
30. Sousa I, Clark TG, Holt R, et al. Polymorphisms in leucine-rich repeat genes are associated with autism spectrum disorder susceptibility in populations of European ancestry. Mol Autism 2010; 1:7.
31. Jonsson L, Ljunggren E, Bremer A, et al. Mutation screening of melatonin-related genes in patients with autism spectrum disorders. BMC Med Genomics 2010; 3:10.
32. Chaste P, Clement N, Mercati O, et al. Identification of pathway-biased and deleterious melatonin receptor mutants in autism spectrum disorders and in the general population. PLoS One 2010; 5:e11495.
33. Holt R, Barnby G, Maestrini E, et al. Linkage and candidate gene studies of autism spectrum disorders in European populations. Eur J Hum Genet 2010; 18:1013-1019.
34. Meechan DW, Tucker ES, Maynard TM, LaMantia AS. Diminished dosage of 22q11 genes disrupts neurogenesis and cortical development in a mouse model of 22q11 deletion/DiGeorge syndrome. Proc Natl Acad Sci USA 2009; 106:16434-16445.
35. Glessner JT, Wang K, Cai G, et al. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 2009; 459:569-573.
36. Morrow EM, Yoo SY, Flavell SW, et al. Identifying autism loci and genes by tracing recent shared ancestry. Science 2008; 321:218-223. (Pubitemid 351989087)
37. Rosenfeld JA, Ballif BC, Torchia BS, et al. Copy number variations associated with autism spectrum disorders contribute to a spectrum of neurodevelop-mental disorders. Genet Med 2010; 12:694-702.
38. Garbett K, Ebert PJ, Mitchell A, et al. Immune transcriptome alterations in the temporal cortex of subjects with autism. Neurobiol Dis 2008; 30:303-311.
39. Abu-Elneel K, Liu T, Gazzaniga FS, et al. Heterogeneous dysregulation of microRNAs across the autism spectrum. Neurogenetics 2008; 9:153-161.
40. Hu VW, Sarachana T, Kim KS, et al. Gene expression profiling differentiates autism case-controls and phenotypic variants of autism spectrum disorders: evidence for circadian rhythm dysfunction in severe autism. Autism Res 2009; 2:78-97.
41. Sarachana T, Zhou R, Chen G, et al. Investigation of posttranscriptional gene regulatory networks associated with autism spectrum disorders by microRNA expression profiling of lymphoblastoid cell lines. Genome Med 2010; 2:23.
42. Talebizadeh Z, Butler MG, Theodoro MF. Feasibility and relevance of examining lymphoblastoid cell lines to study role of microRNAs in autism. Autism Res 2008; 1:240-250.
43. Ghahramani Seno MM, Hu P, Gwadry FG, et al. Gene and miRNA expression profiles in autism spectrum disorders. Brain Res 2011; 1380:85-97.
44. Small EM, O'Rourke JR, Moresi V, et al. Regulation of PI3-kinase/Akt signaling by muscle-enriched microRNA-486. Proc Natl Acad Sci USA 2010; 107:4218-4223.
45. Antunes-Martins A, Mizuno K, Irvine EE, et al. Sex-dependent up-regulation of two splicing factors, Psf and Srp20, during hippocampal memory formation. Learn Mem 2007; 14:693-702. (Pubitemid 350036776)
46. Imayoshi I, Sakamoto M, Yamaguchi M, et al. Essential roles of Notch signaling in maintenance of neural stem cells in developing and adult brains. J Neurosci 2010; 30:3489-3498.
47. Caglayan AO. Genetic causes of syndromic and nonsyndromic autism. Dev Med Child Neurol 2010; 52:130-138.
48. Wegiel J, Kuchna I, Nowicki K, et al. The neuropathology of autism: defects of neurogenesis and neuronal migration, and dysplastic changes. Acta Neu-ropathol 2010; 119:755-770.
49. State MW. The genetics of child psychiatric disorders: focus on autism and Tourette syndrome. Neuron 2010; 68:254-269.
50. Skuse DH. Rethinking the nature of genetic vulnerability to autistic spectrum disorders. Trends Genet 2007; 23:387-395. (Pubitemid 47088014)
51. St Pourcain B, Wang K, Glessner JT, et al. Association between a high-risk autism locus on 5p14 and social communication spectrum phenotypes in the general population. Am J Psychiatry 2010; 167:1364-1372.
52. Perche O, Laumonnier F, Baala L, et al. Autism, genetics and synaptic function alterations (in French). Pathol Biol (Paris) 2010; 58:381-386.
53. Smith SD, Grigorenko E, Willcutt E, et al. Etiologies and molecular mechanisms of communication disorders. J Dev Behav Pediatr 2010; 31:555-563.
54. Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010; 86:749-764.
55. Shen Y, Dies KA, Holm IA, et al. Clinical genetic testing for patients with autism spectrum disorders. Pediatrics 2010; 125:e727-e735.
56. Weiss LA, Shen Y, Korn JM, et al. Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med 2008;358:667-675. (Pubitemid 351240746)
57. Kumar RA, Kara Mohamed S, Sudi J, et al. Recurrent 16p11.2 microdeletions in autism. Hum Mol Genet 2008; 17:628-638. (Pubitemid 351201774)
58. Marshall CR, Noor A, Vincent JB, et al. Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet 2008; 82:477-488.
59. Hogart A, Wu D, LaSalle JM, Schanen NC. The comorbidity of autism with the genomic disorders of chromosome 15q11.2-q13. Neurobiol Dis 2010; 38:181-191.
60. Kitsiou-Tzeli S, Tzetis M, Sofocleous C, et al. De novo interstitial duplication of the 15q11.2-q14 PWS/AS region of maternal origin: Clinical description, array CGH analysis, and review of the literature. Am J Med Genet A 2010; 152A:1925-1932.
61. Abu-Amero KK, Hellani AM, Salih MA, et al. A de novo marker chromosome derived from 9p in a patient with 9p partial duplication syndrome and autism features: genotype-phenotype correlation. BMC Med Genet 2010; 11:135.
62. Bucan M, Abrahams BS, Wang K, et al. Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes. PLoS Genet 2009; 5:e1000536.
63. McBride KL, Varga EA, Pastore MT, et al. Confirmation study of PTEN mutations among individuals with autism or developmental delays/mental retardation and macrocephaly. Autism Res 2010; 3:137-141.
64. Garbern JY, Neumann M, Trojanowski JQ, et al. A mutation affecting the sodium/proton exchanger, SLC9A6, causes mental retardation with tau deposition. Brain 2010; 133:1391-1402.
65. Sakurai T, Ramoz N, Barreto M, et al. Slc25a12 disruption alters myelination and neurofilaments: a model for a hypomyelination syndrome and childhood neurodevelopmental disorders. Biol Psychiatry 2010; 67:887-894.
66. Palmieri L, Papaleo V, Porcelli V, et al. Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC1. Mol Psychiatry 2010; 15:38-52.
67. Handley MT, Lian LY, Haynes LP, Burgoyne RD. Structural and functional deficits in a neuronal calcium sensor-1 mutant identified in a case of autistic spectrum disorder. PLoS One 2010; 5:e10534.
68. Yang SY, Cho SC, Yoo HJ, et al. Association study between single nucleotide polymorphisms in promoter region of AVPR1A and Korean autism spectrum disorders. Neurosci Lett 2010; 479:197-200.
69. Dolen G, Carpenter RL, Ocain TD, Bear MF. Mechanism-based approaches to treating fragile X. Pharmacol Ther 2010; 127:78-93.
70. Sharma A, Hoeffer CA, Takayasu Y, et al. Dysregulation of mTOR signaling in fragile X syndrome. J Neurosci 2010; 30:694-702.
71. Ehninger D, de Vries PJ, Silva AJ. From mTOR to cognition: molecular and cellular mechanisms of cognitive impairments in tuberous sclerosis. J Intellect Disabil Res 2009; 53:838-851.
72. Hoeffer CA, Klann E. mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci 2010; 33:67-75.
73. Dahlhaus R, El-Husseini A. Altered neuroligin expression is involved in social deficits in a mouse model of the fragile X syndrome. Behav Brain Res 2010; 208:96-105.
74. Bakkaloglu B, O'Roak BJ, Louvi A, et al. Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders. Am J Hum Genet 2008; 82:165-173. (Pubitemid 351735952)
75. Bruining H, de Sonneville L, Swaab H, et al. Dissecting the clinical hetero- geneity of autism spectrum disorders through defined genotypes. PLoS One 2010; 5:e10887.
76. McCarthy SE, Makarov V, Kirov G, et al. Microduplications of 16p11.2 are associated with schizophrenia. Nat Genet 2009; 41:1223-1227.
77. Vassos E, Collier DA, Holden S, et al. Penetrance for copy number variants associated with schizophrenia. Hum Mol Genet 2010; 19:3477-3481.
78. Guilmatre A, Dubourg C, Mosca AL, et al. Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation. Arch Gen Psychiatry 2009; 66:947-956.
79. Friedman JI, Vrijenhoek T, Markx S, et al. CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy. Mol Psychiatry 2008; 13:261 - 266. (Pubitemid 351272653)
80. Pagnamenta AT, Bacchelli E, de Jonge MV, et al. Characterization of a family with rare deletions in CNTNAP5 and DOCK4 suggests novel risk loci for autism and dyslexia. Biol Psychiatry 2010; 68:320-328.
81. Verkerk AJ, Mathews CA, Joosse M, et al. CNTNAP2 is disrupted in a family with Gilles de la Tourette syndrome and obsessive compulsive disorder. Genomics 2003; 82:1-9. (Pubitemid 36693915)
82. Lawson-Yuen A, Saldivar JS, Sommer S, Picker J. Familial deletion within NLGN4 associated with autism and Tourette syndrome. Eur J Hum Genet 2008; 16:614-618. (Pubitemid 351594128)
83. Kantojarvi K, Onkamo P, Vanhala R, et al. Analysis of 9p24 and 11 p12-13 regions in autism spectrum disorders: rs1340513 in the JMJD2C gene is associated with ASDs in Finnish sample. Psychiatr Genet 2010;20:102-108.
84. Delorme R, Betancur C, Scheid I, et al. Mutation screening of NOS1APgene in a large sample of psychiatric patients and controls. BMC Med Genet 2010; 11:108.
85. Toro R, Konyukh M, Delorme R, et al. Key role for gene dosage and synaptic homeostasis in autism spectrum disorders. Trends Genet 2010; 26:363-372.
86. Nguyen A, Rauch TA, Pfeifer GP, Hu VW. Global methylation profiling of lymphoblastoid cell lines reveals epigenetic contributions to autism spectrum disorders and a novel autism candidate gene, RORA, whose protein product is reduced in autistic brain. FASEB J 2010; 24:3036-3051.
87. Curran LK, Newschaffer CJ, Lee LC, et al. Behaviors associated with fever in children with autism spectrum disorders. Pediatrics 2007; 120:e1386-e1392. (Pubitemid 350223656)
88. Grafodatskaya D, Chung B, Szatmari P, Weksberg R. Autism spectrum disorders and epigenetics. J Am Acad Child Adolesc Psychiatry 2010; 49:794-809.
89. Tansey KE, Brookes KJ, Hill MJ, et al. Oxytocin receptor (OXTR) does not play a major role in the aetiology of autism: genetic and molecular studies. Neurosci Lett 2010; 474:163-167.
90. Gregory SG, Connelly JJ, Towers AJ, et al. Genomic and epigenetic evidence for oxytocin receptor deficiency in autism. BMC Med 2009; 7:62.
91. Gurrieri F, Neri G. Defective oxytocin function: a clue to understanding the cause of autism? BMC Med 2009; 7:63.
92. Sigurdsson T, Stark KL, Karayiorgou M, et al. Impaired hippocampal-pre-frontal synchrony in a genetic mouse model of schizophrenia. Nature 2010; 464:763-767.
93. Gepner B, Feron F. Autism: a world changing too fast for a mis-wired brain? Neurosci Biobehav Rev 2009; 33:1227-1242.
94. Lichtenstein P, Carlstrom E, Rastam M, et al. The genetics of autism spectrum disorders and related neuropsychiatric disorders in childhood. Am J Psychiatry 2010; 167:1357-1363.
95. Sebat J, Lakshmi B, Malhotra D, et al. Strong association of de novo copy number mutations with autism. Science 2007; 316:445-449. (Pubitemid 46651493)
96. Walsh T, McClellan JM, McCarthy SE, et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008; 320:539-543. (Pubitemid 351590668)
97. Ching MSL, Shen Y, Tan W-H, et al. Deletions of NRXN1 (neurexin-1) predispose to a wide spectrum of developmental disorders. Am J Med Genet B Neuropsychiatr Genet 2010; 153B:937-947.
98. Daoud H, Bonnet-Brilhault F, Vedrine S, et al. Autism and nonsyndromic mental retardation associated with a de novo mutation in the NLGN4X gene promoter causing an increased expression level. Biol Psychiatry 2009; 66:906-910.
99. Noor A, Whibley A, Marshall CR, et al. Disruption at the PTCHD1 locus on Xp22.11 in autism spectrum disorder and intellectual disability. Sci Transl Med 2010; 2:49ra68.
100. Barrionuevo F, Scherer G. SOX E genes: SOX9 and SOX8 in mammalian testis development. Int J Biochem Cell Biol 2010; 42:433-436.
101. Baron-Cohen S. The extreme-male-brain theory of autism. In:Tager-Flusberg H, editor. Neurodevelopmental disorders. Cambridge, MA: MIT Press; 1999.
102. Rubenstein JL. Three hypotheses for developmental defects that may underlie some forms of autism spectrum disorder. Curr Opin Neurol 2010; 23: 118-123.
103. Herbert MR. Contributions of the environment and environmentally vulner- able physiology to autism spectrum disorders. Curr Opin Neurol 2010; 23:103-110.
104. Ming X, Johnson WG, Stenroos ES, Mars A, Lambert GH, Buyske S. Genetic variant of glutathione peroxidase 1 in autism. Brain Dev 2010; 32:105-109.
105. Ashwood P, Krakowiak P, Hertz-Picciotto I, et al. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun 2011; 25:40-45.
106. Hunter JW, Mullen GP, McManus JR, et al. Neuroligin-deficient mutants of C. elegans have sensory processing deficits and are hypersensitive to oxidative stress and mercury toxicity. Dis Model Mech 2010; 3:366-376.
107. Witter FR, Zimmerman AW, Reichmann JP, Connors SL. In utero beta 2 adrenergic agonist exposure and adverse neurophysiologic and behavioral outcomes. Am J Obstet Gynecol 2009; 201:553-559.